Niederfellner, G.
F. Hoffmann-La Roche AG · Centre National de la Recherche Scientifique · Inserm · Centre de Recherche en Cancérologie de Lyon
2 papers on CoChatORCID 0000-0001-5487-2929
Most cited papers
- Verified
Heregulin‐dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
Wallasch, C., Weiss, F. U., Niederfellner, G., Jallal, B., Issing, W., & Ullrich, A. (1995) · The EMBO Journal
HER2/EGFR in Cancer ResearchPI3K/AKT/mTOR signaling in cancer
Cited by 406
- Verified
Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
Herter, S., Herting, F., Mundigl, O., Waldhauer, I., Weinzierl, T., Fauti, T., Muth, G., Ziegler-Landesberger, D., Van Puijenbroek, E., Lang, S., et al. (2013) · Molecular Cancer Therapeutics
Lymphoma Diagnosis and TreatmentMonoclonal and Polyclonal Antibodies Research
Cited by 366
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free